View Author
patient treatment response hepatitis hepatitis c therapy interferon ribavirin genotype study peginterferon virological response virological liver group virus combination concentration effect induction genotype 1 trial amantadine cirrhosis hepatitis c virus chapter peg-ifn infection result hcv rna 48 weeks virological response rates interferon alfa -2b baseline serum level hepatology hepatitis c patients analysis number table high-dose fatigue characteristic plasma blood biopsy figure month randomized tyrosine non-responder cd 8+ cells activity 24 weeks assay pharmacokinetic population signi peginterferon alfa -2a period replicon difference relapse weight t-cell responder schalm sw patien response rates factor outcome shiffman ml portal placebo sample schedule svr rates randomised trial response rate
6 Most Recent Publications
|
A giant antral ulceration evoked by a rare cause of single-vessel chronic GI ischemia
(Article)
Vrolijk, J.M. Noord, D. van Verhagen, H.J.M. Pattynama, P.M.T. Mensink, P.B.F. |
2010-07-01
|
|
No beneficial effects of amantadine in treatment of chronic hepatitis C patients
(Article)
Soest, H. van Schaar, P.J. van der Sluys Veer, A. van der Siersema, P.D. Schipper, M.E.I. Erpecum, K.J. van Boland , G.J. Koek, G.H. Vries, R.A. de Ooteghem, N.A. Hoek, B. van Drenth, J.P.H. Vrolijk, J.M. Lieverse, R.J. Houben, P. |
2010-07-01
|
|
γ-glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-α-2b in chronic hepatitis C non-responders
(Article)
Bergmann, J.F. Vrolijk, J.M. Janssen, H.L.A. Schalm, S.W. Knegt, R.J. de Schaar, P.J. van der Vroom, B. Hoek, B. van Sluys Veer, A. van der Vries, R.A. de Verhey, E. Hansen, B.E. Brouwer, J.T. |
2007-11-01
|
|
Response in Hepatitis C Virus Non-Responders
(Doctoral Thesis)
Vrolijk, J.M. |
2005-05-04
|
|
The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis.
(Article)
Fekkes, D. Vrolijk, J.M. Buuren, H.R. van Borg, P.C.J. ter |
2005-03-24
|
|
The treatment of hepatitis C: history, presence and future
(Article)
Vrolijk, J.M. Knegt, R.J. de Veldt, B.J. Orlent, H. Schalm, S.W. |
2004-01-01
|
